US Renal Data System 2013 Annual Data Report

医学 透析 肾脏疾病 血液透析 终末期肾病 重症监护医学 药方 人口 心理干预 疾病 处方药 急诊医学 蓝卡 急性肾损伤 内科学 环境卫生 精神科 药理学
作者
Allan J. Collins,Robert N. Foley,Blanche M. Chavers,David T. Gilbertson,Charles A. Herzog,Areef Ishani,Kirsten L. Johansen,Bertram L. Kasiske,Nancy G. Kutner,Jiannong Liu,Wendy L. St. Peter,Haifeng Guo,Yan Hu,Allyson M Kats,Shuling Li,Suying Li,Julia Maloney,Tricia Roberts,M. A. Skeans,Jon J. Snyder,Craig A. Solid,Bryn Thompson,Eric D. Weinhandl,Hui Xiong,Akeem Yusuf,David Zaun,Cheryl Arko,Shu‐Cheng Chen,Frank Daniels,James Ebben,Eric Frazier,Roger N. Johnson,Daniel Sheets,Xinyue Wang,Beth Forrest,Delaney Berrini,Edward Constantini,Susan Everson,Paul W. Eggers,Lawrence Y. Agodoa
出处
期刊:American Journal of Kidney Diseases [Elsevier BV]
卷期号:63 (1): A7-A7 被引量:387
标识
DOI:10.1053/j.ajkd.2013.11.001
摘要

This 25th US Renal Data System (USRDS) Annual Data Report contains data through 2011, and again examines chronic kidney disease (CKD) in the United States, characterizing its burden in the general population. In the first section, we offer important data on the impact of CKD, and use the CKD staging system as a predictor of morbidity and mortality. We also compare hospitalization and rehospitalization rates and evaluate adverse events and interventions associated with cardiovascular disease. And we continue to report Medicare Part D prescription drug use, acute kidney injury (AKI), and costs associated with CKD.The second section focuses on end-stage renal disease (ESRD). At the end of 2011, 615,899 dialysis and transplant patients were receiving treatment for ESRD—a 3.2% increase from 2010. There were 115,643 new cases of ESRD reported; this was a 1.5% decrease from 2010 and the first decline in actual counts of new ESRD patients over the last 30 years. Total Medicare costs rose 5% in 2011, to $549 billion, while costs for ESRD reached $34.3 billion, accounting for 6.3% of the Medicare budget and an increase of 5.4% from 2010. Data now show similar reductions in mortality rates among patients of all vintages, and there is continued progress in the first year of hemodialysis therapy. Expanded data on rehospitalization after a prior discharge show that 36% of hemodialysis patients are rehospitalized within 30 days of discharge, a number substantially higher than rates found in the general Medicare and CKD populations. Of particular concern are rates of hospitalization for infection in the hemodialysis population, which have increased 43% since 1993. We continue our evaluation of major changes occurring after the start of the bundled Prospective Payment System in January 2011, looking at providers switching to the new system, at pre- and post-bundle changes in the use of erythropoietin, intravenous iron, and vitamin D, and at changes in hemoglobin levels and trends in transfusion events. This 25th US Renal Data System (USRDS) Annual Data Report contains data through 2011, and again examines chronic kidney disease (CKD) in the United States, characterizing its burden in the general population. In the first section, we offer important data on the impact of CKD, and use the CKD staging system as a predictor of morbidity and mortality. We also compare hospitalization and rehospitalization rates and evaluate adverse events and interventions associated with cardiovascular disease. And we continue to report Medicare Part D prescription drug use, acute kidney injury (AKI), and costs associated with CKD. The second section focuses on end-stage renal disease (ESRD). At the end of 2011, 615,899 dialysis and transplant patients were receiving treatment for ESRD—a 3.2% increase from 2010. There were 115,643 new cases of ESRD reported; this was a 1.5% decrease from 2010 and the first decline in actual counts of new ESRD patients over the last 30 years. Total Medicare costs rose 5% in 2011, to $549 billion, while costs for ESRD reached $34.3 billion, accounting for 6.3% of the Medicare budget and an increase of 5.4% from 2010. Data now show similar reductions in mortality rates among patients of all vintages, and there is continued progress in the first year of hemodialysis therapy. Expanded data on rehospitalization after a prior discharge show that 36% of hemodialysis patients are rehospitalized within 30 days of discharge, a number substantially higher than rates found in the general Medicare and CKD populations. Of particular concern are rates of hospitalization for infection in the hemodialysis population, which have increased 43% since 1993. We continue our evaluation of major changes occurring after the start of the bundled Prospective Payment System in January 2011, looking at providers switching to the new system, at pre- and post-bundle changes in the use of erythropoietin, intravenous iron, and vitamin D, and at changes in hemoglobin levels and trends in transfusion events. Support: Funding for the USRDS Coordinating Center is provided under contract to the Minneapolis Medical Research Foundation (MMRF; NIH contract HHSN 267 2007 15002C/NO1-DK-7-5002). Financial Disclosure: Relevant financial interests for contributors to the supplement are listed on page e4.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
糖豆发布了新的文献求助10
刚刚
dengqin完成签到 ,获得积分10
1秒前
1秒前
hyz发布了新的文献求助10
2秒前
3秒前
魏为维完成签到,获得积分10
3秒前
糊涂的猎豹完成签到,获得积分10
5秒前
魏为维发布了新的文献求助10
5秒前
dkyt完成签到,获得积分10
7秒前
嵇如雪完成签到,获得积分10
7秒前
8秒前
量子星尘发布了新的文献求助10
8秒前
9秒前
zhouyunan完成签到,获得积分10
9秒前
竹子完成签到,获得积分10
10秒前
11秒前
练习时长两年半应助Yve采纳,获得10
11秒前
金枪鱼完成签到,获得积分10
11秒前
Hello应助谨言采纳,获得10
12秒前
12秒前
英俊的铭应助研友_LkD29n采纳,获得10
12秒前
徐佳达完成签到,获得积分10
13秒前
shenxian82133发布了新的文献求助10
16秒前
李傲寒发布了新的文献求助10
17秒前
Man发布了新的文献求助10
17秒前
hyz完成签到,获得积分10
19秒前
20秒前
科研通AI5应助予安采纳,获得10
21秒前
科研x完成签到,获得积分10
21秒前
23秒前
听说外面下雨了完成签到,获得积分10
24秒前
CipherSage应助李傲寒采纳,获得10
25秒前
刘YF发布了新的文献求助10
29秒前
29秒前
orixero应助ty采纳,获得10
31秒前
32秒前
拉长的冷霜完成签到,获得积分10
32秒前
34秒前
英姑应助ccmaxp采纳,获得10
34秒前
wu先生完成签到,获得积分10
37秒前
高分求助中
A new approach to the extrapolation of accelerated life test data 1000
Picture Books with Same-sex Parented Families: Unintentional Censorship 700
ACSM’s Guidelines for Exercise Testing and Prescription, 12th edition 500
Nucleophilic substitution in azasydnone-modified dinitroanisoles 500
不知道标题是什么 500
Indomethacinのヒトにおける経皮吸収 400
Phylogenetic study of the order Polydesmida (Myriapoda: Diplopoda) 370
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3975543
求助须知:如何正确求助?哪些是违规求助? 3519971
关于积分的说明 11200248
捐赠科研通 3256311
什么是DOI,文献DOI怎么找? 1798213
邀请新用户注册赠送积分活动 877446
科研通“疑难数据库(出版商)”最低求助积分说明 806338